1. Low-dose computed tomography scan and biopsy for assessing lung cancer prevalence and related factors in high-risk populations
    Duy Hoang Tran et al, 2024, Heliyon CrossRef
  2. Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy
    Ziyu Jiang et al, 2022, Journal of Nanomaterials CrossRef
  3. The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
    Jolanta Smok-Kalwat et al, 2023, International Journal of Molecular Sciences CrossRef
  4. A Global Perspective of Cancer Prevalence: The Causative Agent, the Environment, or the Genes?
    Kawthar Mohamed et al, 2023, Handbook of Cancer and Immunology CrossRef
  5. Insights into the Biological Activity and Cytotoxic Mechanism of Epimedium pubigerum
    Gökçe Seyhan et al, 2023, Chemistry & Biodiversity CrossRef
  6. The Association Between Plasma Fatty Acids and Risk of Lung Cancer: A Prospective Cohort Study of the UK Biobank
    Jianv Huang et al, 2024, The Journal of Clinical Endocrinology & Metabolism CrossRef
  7. Label-free electrochemical detection of cancer biomarkers DNA and anti-p53 at tin oxide quantum dot-gold-DNA nanoparticle modified electrode
    Yesurajan Allwin Richard et al, 2023, Bioelectrochemistry CrossRef
  8. Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer
    Mai Thi Le et al, 2023, Heliyon CrossRef
  9. Lung cancer immunotherapy: progress, pitfalls, and promises
    Aritraa Lahiri et al, 2023, Molecular Cancer CrossRef
  10. Biomacromolecule-mediated pulmonary delivery of siRNA and anti-sense oligos: challenges and possible solutions
    Yaseen Hussain et al, 2021, Expert Reviews in Molecular Medicine CrossRef
  11. Design, synthesis and biological evaluation of small molecule fluorescent probes targeting EGFR for tumor detection and treatment
    Depu Song et al, 2023, The Analyst CrossRef
  12. Pan-cancer analysis and experimental validation reveal FAM72D as a potential novel biomarker and therapeutic target in lung adenocarcinoma
    Zonglang Zhou et al, 2024, Gene CrossRef
  13. Oxidative stress in lung cancer
    Amir Mousapasandi et al, 2021, Cancer CrossRef
  14. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
    Giovanna Maria Stanfoca Casagrande et al, 2023, International Journal of Molecular Sciences CrossRef
  15. New discoveries of mdig in the epigenetic regulation of cancers
    Qian Zhang et al, 2019, Seminars in Cancer Biology CrossRef
  16. The Role of Family Health History in Predicting Midlife Chronic Disease Outcomes
    Naomi N. Duke et al, 2021, American Journal of Preventive Medicine CrossRef
  17. Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk
    Virginia Calvo et al, 2024, Lung Cancer CrossRef
  18. Are calcium channel blockers related to lung cancer?
    Ratchanon Rattanathanoo et al, 2023, Drug Target Insights CrossRef
  19. Artificial Intelligence Tools for Refining Lung Cancer Screening
    J. Luis Espinoza et al, 2020, Journal of Clinical Medicine CrossRef
  20. SMAC Mimetics for the Treatment of Lung Carcinoma: Present Development and Future Prospects
    Ruchi Pandey et al, 2024, Mini-Reviews in Medicinal Chemistry CrossRef
  21. Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer
    Kuei-Feng Lin et al, 2017, BMC Pulmonary Medicine CrossRef
  22. Lung cancer mortality trends in Mexico, 1998–2018: the impact of the General Law on Tobacco Control
    Juan Alejandro Torres-Domínguez et al, 2022, Revista Brasileira de Epidemiologia CrossRef
  23. Applications of nanotechnology in the treatment of pulmonary diseases
    Rahit Kumar Dey et al, 2023, Vessel Plus CrossRef
  24. Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer
    Mao-rong Teng et al, 2019, Pathology - Research and Practice CrossRef
  25. Radon Biomonitoring and microRNA in Lung Cancer
    Rakhmet Bersimbaev et al, 2020, International Journal of Molecular Sciences CrossRef
  26. Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update
    Anthony McGuigan et al, 2022, European Journal of Human Genetics CrossRef
  27. A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology
    Ryo Tanaka et al, 2023, FEBS Open Bio CrossRef
  28. Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022
    Valerian Mwenda et al, 2023, PLOS Global Public Health CrossRef
  29. PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities
    Mohammed Ageeli Hakami et al, 2024, Pathology - Research and Practice CrossRef
  30. Modification Role of Dietary Antioxidants in the Association of High Red Meat Intake and Lung Cancer Risk: Evidence from a Cancer Screening Trial
    Jiaqi Yang et al, 2024, Antioxidants CrossRef
  31. Annotation and extraction of age and temporally-related events from clinical histories
    Judy Hong et al, 2020, BMC Medical Informatics and Decision Making CrossRef
  32. Artificial Intelligence in Clinical Trials of Lung Cancer: Current and Future Prospects
    Yuhang Zhang et al, 2024, Intelligent Oncology CrossRef
  33. MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer
    Xiaotian Zhang et al, 2018, International Journal of Oncology CrossRef
  34. Revolutionizing lung cancer treatment: Nanotechnology-driven advances in targeted drug delivery and novel therapeutic strategies
    Shirin Shojaei et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
  35. CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non‐small cell lung cancer by regulating Galectin‐1‐AKT/ERK1/2 signaling
    Bai‐Quan Qiu et al, 2019, Journal of Cellular Physiology CrossRef
  36. Association of CYP19A1 rs28757157 polymorphism with lung cancer risk in the Chinese Han population
    Chan Zhang et al, 2022, World Journal of Surgical Oncology CrossRef
  37. Lycium barbarum polysaccharide reduces lung cancer immunotherapy-related endocrine adverse reactions and improves prognosis via interleukin-2
    Zhiping Lv et al, 2023, Materials Express CrossRef
  38. Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling
    Weijuan Yan et al, 2018, Oncology Letters CrossRef
  39. Construction and case study of a novel lung cancer risk index
    Ali Faghani et al, 2022, BMC Cancer CrossRef
  40. Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives
    Hardeep Singh Tuli et al, 2023, Molecular Biology Reports CrossRef
  41. A label-free immunosensor for the detection of a new lung cancer biomarker, GM2 activator protein, using a phosphomolybdic acid/polyethyleneimine coated gold nanoparticle composite
    Kulrisa Kuntamung et al, 2021, The Analyst CrossRef
  42. Usage of Machine Learning and Deep Learning for Lung Cancer Detection
    Ishaan Dawar et al, 2024, Machine Learning and Generative AI in Smart Healthcare CrossRef
  43. Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed
    Megan I. Mitchell et al, 2024, Journal of Extracellular Vesicles CrossRef
  44. Risk factors for the development of lung cancer around the world: a review
    Hervé Agonsanou et al, 2023, Exploration of Medicine CrossRef
  45. Cancer Screening in the Older Adult
    Koshy Alexander et al, 2024, Geriatric Medicine CrossRef
  46. Genetic Blueprints in Lung Cancer: Foundations for Targeted Therapies
    Andra Dan et al, 2024, Cancers CrossRef
  47. Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities
    Aniket Tiwari et al, 2024, Cancers CrossRef
  48. Polysaccharide-enhanced ARGET ATRP signal amplification for ultrasensitive fluorescent detection of lung cancer CYFRA 21-1 DNA
    Xia Wang et al, 2020, Analytical and Bioanalytical Chemistry CrossRef
  49. Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis
    Lina Ang et al, 2020, Lung Cancer CrossRef
  50. Knowledge, attitude, and practice toward lung cancer risk among offspring of lung cancer patients: a cross-sectional study
    Zeru Luo et al, 2024, Scientific Reports CrossRef
  51. Chinese Expert Consensus Workshop Report: Guideline for permanent iodine‐125 seed implantation of primary and metastatic lung tumors
    Fujun Zhang et al, 2019, Thoracic Cancer CrossRef
  52. Advancements and Challenges in the Image-Based Diagnosis of Lung and Colon Cancer: A Comprehensive Review
    Pragati Patharia et al, 2024, Cancer Informatics CrossRef
  53. Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
    Esha Vallabhaneni et al, 2024, Cancers CrossRef
  54. Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices
    Tony Chen et al, 2024, eBioMedicine CrossRef
  55. Functional studies of lung cancer GWAS beyond association
    Erping Long et al, 2022, Human Molecular Genetics CrossRef
  56. Characterization of germline mutations in familial lung cancer from the Chinese population
    Madiha Kanwal et al, 2018, Gene CrossRef
  57. Plausible Role of Estrogens in Pathogenesis, Progression and Therapy of Lung Cancer
    Claudia Musial et al, 2021, International Journal of Environmental Research and Public Health CrossRef
  58. Alternative splicing in lung cancer
    Alice O. Coomer et al, 2019, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  59. In Vitro Cytotoxicity of Reproductive Stage Withania somnifera Leaf and Stem on HepG2 Cell Line
    Lali Lingfa et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
  60. Cancer Screening in the Older Adult
    Koshy Alexander et al, 2023, Geriatric Medicine CrossRef
  61. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma
    Eriko Harada et al, 2024, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  62. Emerging landscape of circular RNAs in lung cancer
    Wei Hu et al, 2018, Cancer Letters CrossRef
  63. Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges
    Francisco Silva et al, 2022, Journal of Personalized Medicine CrossRef
  64. Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients
    Paola Ulivi et al, 2022, Cancers CrossRef
  65. The Role of Pembrolizumab (Keytruda) in Treating Non-small Cell Lung Cancer
    Linwei Ren, 2023, Highlights in Science, Engineering and Technology CrossRef
  66. A clean environmental week: Let the nature breathe
    Khaled Moustafa, 2017, Science of The Total Environment CrossRef
  67. Genetic Susceptibility to Lung Cancer
    Timothy Craig Allen, 2018, Precision Molecular Pathology of Lung Cancer CrossRef
  68. Chemotherapeutic Protocols for the Treatment of Lung Cancer
    Iago Dillion Lima Cavalcanti, 2022, Chemotherapy Protocols and Infusion Sequence CrossRef
  69. Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
    Anais Del Curatolo et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
  70. Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases
    Roman Teo Oliynyk, 2019, Journal of Personalized Medicine CrossRef
  71. Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal
    Dawei Yang et al, 2020, Journal of Translational Medicine CrossRef
  72. Risk Factors for Lung Cancer in the Province of Lecce: Results from the PROTOS Case–Control Study in Salento (Southern Italy)
    Fabrizio Minichilli et al, 2022, International Journal of Environmental Research and Public Health CrossRef
  73. A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer
    Hanie Abolfathi et al, 2023, Respiratory Research CrossRef
  74. Surgical Treatment of Lung Cancer
    Haley Hoy et al, 2019, Critical Care Nursing Clinics of North America CrossRef
  75. Lung Cancer Mortality in China
    Ning Wang et al, 2019, Chest CrossRef
  76. Validity of an NGS‑based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
    Wei Cao et al, 2019, Oncology Letters CrossRef
  77. Molecular Pathogenesis of Hereditary Lung Cancer: a Literature Review
    Souraya Rammal et al, 2021, Pharmacogenomics CrossRef
  78. The Association between Family History of Lung Cancer and Development of Lung Cancer: Analysis from the KoGES Data in Korea
    Sang Hyuk Kim et al, 2024, Cancers CrossRef
  79. Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases
    Roman Teo Oliynyk, 2019, International Journal of Molecular Sciences CrossRef
  80. Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review
    Leila Gholami et al, 2023, Current Medicinal Chemistry CrossRef
  81. A new approach used in docking study for predicting the combination drug efficacy in EML4-ALK target of NSCLC
    Saleena Younus et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
  82. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
    Jinyoung Byun et al, 2022, Nature Genetics CrossRef
  83. Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations
    Matthew R. Trendowski et al, 2023, Cancer Epidemiology, Biomarkers & Prevention CrossRef
  84. New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
    Ramon Andrade de Mello et al, 2020, Journal of Clinical Medicine CrossRef